Author: Aucta Pharma

Posted Date:

February 7, 2026

Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line

Aucta Pharma

February 7, 2026